参考文献/References:
[1] Chen C,Xie L,Ren T,et al.Immunotherapy for osteosarcoma: Fundamental mechanism,rationale,and recent breakthroughs[J].Cancer Lett,2021,500:1-10.
[2] 李世文,陈建百,郝海静,等.不同人骨肉瘤细胞系特点及其在实验研究中应用潜力的研究进展[J].中国骨与关节杂志,2022,11(3):221-229.
[3] Yin G,Fan J,Zhou W,et al.ERK inhibition sensitizes CZ415-induced anti-osteosarcoma activity in vitro and in vivo [J].Oncotarget,2017,8(47):82027-82036.
[4] Qin J,Wang R,Zhao C,et al.Notch signaling regulates osteosarcoma proliferation and migration through Erk phosphorylation [J].Tissue and Cell,2019,59(11):51-61.
[5] 丁聚贤,谢兴文,许伟,等.中医药在骨肉瘤放化疗中的作用研究进展[J].中医正骨,2018,30(5):43-49.
[6] Corre I,Verrecchia F,Crenn V,et al.The osteosarcoma microenvironment: A complex but targetable ecosystem [J].Cells,2020,9(4):976.
[7] Yang D,Xu T,Fan L,et al.Correction to: microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis [J].J Exp Clin Cancer Res,2021,40(1):17-24.
[8] Bachle M,Kohal R J.A systematic review of the influence of different titanium surfaces on proliferation,differentiation and protein synthesis of osteoblast-like MG63 cells [J].Clin Oral Implants Res,2004,15(6):683-692.
[9] 秦刚,李海东,徐苏洋,等.蜂毒素对荷骨肉瘤裸鼠体瘤内皮祖细胞数量和细胞因子HIF-1α及SDF-1α的影响[J].广东医学,2013,34(21):3226-3229.
[10] Samatar A A,Poulikakos P I.Targeting RAS-ERK signalling in cancer: promises and challenges [J].Nat Rev Drug Discov,2014,13(12):928-942.
[11] 秦文英,陈丽华,高方方.普鲁卡因通过ERK/MAPK/FAK通路抑制骨肉瘤细胞增殖、迁移和侵袭[J].中国比较医学杂志,2021,31(11):108-113.
[12] 胡俊,李卫,袁忠,等.siRNA沉默ERK-1基因对骨肉瘤细胞U-2OS基质金属蛋白酶-9表达的影响[J].当代医学,2019,25(4):4-7.